JPS5774088A - Purification of estrase - Google Patents

Purification of estrase

Info

Publication number
JPS5774088A
JPS5774088A JP15262580A JP15262580A JPS5774088A JP S5774088 A JPS5774088 A JP S5774088A JP 15262580 A JP15262580 A JP 15262580A JP 15262580 A JP15262580 A JP 15262580A JP S5774088 A JPS5774088 A JP S5774088A
Authority
JP
Japan
Prior art keywords
estrase
sodium chloride
buffer solution
support
alanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15262580A
Other languages
Japanese (ja)
Inventor
Setsuo Fujii
Toshiyuki Honda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toho Pharmaceutical Industries Co Ltd
Original Assignee
Toho Pharmaceutical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toho Pharmaceutical Industries Co Ltd filed Critical Toho Pharmaceutical Industries Co Ltd
Priority to JP15262580A priority Critical patent/JPS5774088A/en
Publication of JPS5774088A publication Critical patent/JPS5774088A/en
Pending legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

PURPOSE: Estrase obtained from internal organs of mammalian animals is simply and efficiently purified by utilizing its characteristic affinity to the residual group of glycine or alanine.
CONSTITUTION: Glycine or alanine is bonded through a spacer with a support such agarose or dextran and the resultant support is brought into contact with crude estrase obtained from internal organs of mammalian animals. Then, contaminating foreign proteins are eluted with a buffer solution free from sodium chloride, preferably a phosphate buffer solution of about 7.4pH, then, the estrase held on the support is eluted with a buffer solution containing less than 0.2M sodium chloride, preferably by the gradient method in which the concentration of sodium chloride gradually increases from 0 to 0.2M.
COPYRIGHT: (C)1982,JPO&Japio
JP15262580A 1980-10-29 1980-10-29 Purification of estrase Pending JPS5774088A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15262580A JPS5774088A (en) 1980-10-29 1980-10-29 Purification of estrase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15262580A JPS5774088A (en) 1980-10-29 1980-10-29 Purification of estrase

Publications (1)

Publication Number Publication Date
JPS5774088A true JPS5774088A (en) 1982-05-10

Family

ID=15544465

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15262580A Pending JPS5774088A (en) 1980-10-29 1980-10-29 Purification of estrase

Country Status (1)

Country Link
JP (1) JPS5774088A (en)

Similar Documents

Publication Publication Date Title
ES8100502A1 (en) A PROCEDURE TO PURIFY PROTEINS WITH MOLECULAR WEIGHTS OVER 12,000, IN PARTICULAR INTERFERON
ES8501413A1 (en) PROCEDURE TO PREPARE A SAFE MEDICATION AGAINST HEPATITIS CONTAINING PROTEIN CALLED INACTIVATOR CL.
DK60586D0 (en) INHIBIN ISOLATED FROM OVARIE FOLLICLE LIQUID AND PROCEDURE FOR INHIBIN ISOLATION AND CLEANING
BG60256B1 (en) RECOMBINANT METHOD FOR LYMPHOTOXIN
MD430C2 (en) Method for human leucocytar interferone preparation
CA1267497C (en) Protein recovery
Chan et al. Nonidentity of subunits of rabbit muscle aldolase.
KR880701246A (en) Recombinant Pepot Surfactant Protein
KR840003422A (en) Method of producing homogeneous human immune interferon
ATE43639T1 (en) PROCESSES FOR REMOVAL OF IMPURITIES FROM LEUKOCYTIN INTERFERON PREPARATIONS AND THE PURIFIED LEUKOCYTIN INTERFERON SO PRODUCED.
Lai Studies on the structure of rabbit muscle aldolase: Determination of the primary structure of the COOH-terminal BrCN peptide; the complete sequence of the subunit polypeptide chain
EP0152346A3 (en) Method for purifying gamma-interferon
Malhotra Purification and characterization of dicoumarol-induced prothrombins. II. Barium oxalate atypical (5-Gla) variant
Kobayashi et al. Isolation of eburnetoxin, a vasoactive substance from the Conus eburneus venom
TAMURA et al. Purification and Properties of Whale Thyroid-stimulating Hormone I. Evidence for the Presence of Multiple Components and Their Origin
Rocklin et al. Human leukocyte inhibitory factor (LIF): use of benzoyl L-arginine ethyl ester to detect LIF activity
ATE76082T1 (en) PURIFICATION METHOD FOR ANTIBODIES.
Mäkinen et al. Aminopeptidases in the serum of pregnant and nonpregnant women
JPS57203015A (en) Purifying method of human urinary callicrein
Sawabu et al. Purification and Some Properties of Novel γ‐Glutamyl Transpeptidase Isoenzyme Occurring in Sera of Patients with Hepatoma
TAMURA et al. Purification and Properties of Whale Thyroid-stimulating Hormone: II. Isolation of Multiple Components
DE3470747D1 (en) Immune interferon and method for its purification
Litwack Chromatographic Studies of Rat Kidney Lysozyme.
MAO STUDIES OF ISOLATION, PURIFICATION AND IODINATION OF?-BUNGAROTOXIN
SU1679796A1 (en) METHOD OF OBTAINING DNA OF VECTORS BASED ON BACTERIOPHAG LAMBDA